Genscript Biotech Stock

Genscript Biotech P/B

Delisted·Jun 18, 2026

P/B (Price-to-Book Ratio) of Genscript Biotech (1548.HK) as of Aug 6, 2026.

P/B

0.00

Last updated:

P/B (Price-to-Book Ratio) of Genscript Biotech is 2026 0.00 . P/B (Price-to-Book Ratio) of Genscript Biotech was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Genscript Biotech Stock analysis

What does Genscript Biotech do? GenScript Biotech Corp. is a leading biotechnology company founded in Nanjing, China in 2002. Today, it is headquartered in New Jersey, USA and operates worldwide. Genscript Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genscript Biotech stock

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Genscript Biotech since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Genscript Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Genscript Biotech

All Key Metrics — Genscript Biotech